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ABSTRACT OF THE THESIS
CELLULAR EVENTS UNDER FLOW STATES PERTINENT TO HEART
VALVE FUNCTION
by
Glenda Castellanos
Florida International University, 2015
Miami, Florida
Professor Sharan Ramaswamy, Major Professor
Heart valve disease (HVD) or a damaged valve can severely compromise the
heart's ability to pump efficiently. Balloon valvuloplasty is preferred on neonates with
aortic valve stenosis. Even though this procedure decreases the gradient pressure across
the aortic valve, restenosis is observed soon after balloon intervention. Tissue
engineering heart valves (TEHV), using bone marrow stem cells (BMSCs) and
biodegradable scaffolds, have been investigated as an alternative to current non-viable
prosthesis. By observing the changes in hemodynamics following balloon aortic
valvuloplasty, we could uncover a potential cause for rapid restenosis after balloon
intervention. Subsequently, a tissue engineering treatment strategy based on BMSC
mechanobiology could be defined. Understanding and identifying the mechanisms by
which cytoskeletal changes may lead to cellular differentiation of a valvular phenotype is
a first critical step in enhancing the promotion of a robust valvular phenotype from
BMSCs.
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CHAPTER 1: INTRODUCTION

Valvular heart disease is a serious cardiovascular complication. Approximately 275000
people in the United States undergo heart valve replacement every year; ~5000 are
children1. Heart valves perform a critical role in maintaining unidirectional blood flow.
The tissue and cells that constitute the leaflets must have unique characteristics that allow
them to open and close properly, as well as remodel as needed2. The leaflets also
experience complex mechanical stresses which their composition and structure allows
them to endure3. They are comprised of three different layers, which include the fibrosa
(facing the artery), ventricularis (facing the ventricle), and the spongiosa, which is
located between the fibrosa and the ventricularis4. Similar to blood vessels, the surface of
the heart valves are lined with endothelial cells, which have been known to have the
ability to sense and respond to different mechanical and hemodynamic environments, and
rapidly change their behavior2,3. However, in vitro studies have suggested that vascular
and valvular endothelial cells are distinct in their response to hemodynamics2.
Congenital heart defects are the most common birth defect, with about 1% of the
population being affected by them4. Around 24.5% of neonatal mortality is due to
congenital heart defects5, one of the most severe being critical aortic valve stenosis
(AVS), a life-threatening condition with high morbidity despite early intervention. Open
surgical valvotomy and a less invasive procedure, transcatheter balloon valvuloplasty of
the aortic valve, are two of the most used and recognized procedures done TO neonates
with AVS. Balloon valvuloplasty has been shown to reduce the pressure gradient across
the aortic valve around 60%6. Even though this procedure has shown promising results,
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reintervention following aortic balloon valvuloplasty is high due to several factors,
including restenosis in one third of the patients6. Recent studies have shown that in
vascular endothelial cells, flow patterns are critical in the sense that they influence the
initiation of atherosclerosis, in-stent restenosis, and bypass graft failure. After balloon
valvuloplasty, there is a relief in the pressure gradient across the aortic valve, however
the hemodynamics do not resemble that of a normal valve, which could play an important
role in the cause of restenosis. Valvular leaflet remodeling has been traced to endothelial
cell dysfunction and denudation2, which is the primary suspect for the cause of restenosis
in patients with balloon valvuloplasty. Valvular endothelial cells, like vascular
endothelial cells, are known to remodel in response to hemodynamic environments by
sensing the mechanical signals, and reorganizing the cytoskeletal filaments and the focal
adhesion complexes2. The process by which valvular endothelial cells remodel after
balloon intervention is not well known. By evaluating the changes in valvular endothelial
cells’ intracellular structural proteins in response to flow profiles following balloon
intervention, we can delineate potential abnormal responses, which could be linked to the
underlying cause of rapid restenosis after balloon implantation.
The need for reintervention after balloon valvuloplasty is very common, eventually
leading to surgical valve repair or valve replacement. Tissue engineering heart valves
(TEHVs), based on bone marrow stem cells (BMSCs) and biodegradable scaffolds, have
been investigated as the next step to current prosthesis limitations, particularly the lack of
somatic growth, which is critical in the pediatric patient population7. BMSCs are a
promising cell source due to their accessibility and phenotypic plasticity under

2

biochemical and mechanical stimulation. TEHVs have shown a resemblance in the trilayer structure found in the heart valve; however structural differences such as the
absence of surface ridges in TEHVs are evident and may contribute to the early failure of
these constructs8. Recent studies have shown that shear stress can regulate the
proliferation and differentiation of BMSCs through a variety of signaling pathways9.
Heart valves experience mechanical stresses, including cyclic flexure, tensile, and fluidinduced shear stress patterns, such as oscillatory shear stresses (OSS), during their
lifetime10. It was previously demonstrated that coupled flexure and flow environments
augmented tissue formation using PGA:PLLA scaffolds seeded with BMSCs11. At the
intracellular scale, changes in BMSC cytoskeleton have also been observed when BMSCs
were exposed to fluid induced shear stress. Alterations in F-actin structure and
distribution may thus be closely linked to gene expression and protein synthesis in the
mechanobiology of stem cells2. In addition, we believe that focal adhesion patterns are
important to observe, as they sense mechanical forces and act as conduits for translating
these physical forces into chemical and genetic cellular responses. OSS may also further
regulate BMSC structure, hence its phenotype specifically towards the valvular lineage.
In this investigation, we are going to apply OSS to growing valvular endothelial cells and
BMSCs to understand their structural changes to this environment, which would
subsequently have implications to the underlying cellular basis for restenosis and for
optimizing heart valve tissue engineering protocols, respectively
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SPECIFIC AIMS
Specific Aim 1: To compare changes in the hemodynamic environment after balloon
valvulplasty compared to a normal patient using a computational fluid dynamic model
(ANSYS CFD).
Specific Aim 2: To observe changes on F-actin and nuclear deformation on bone
marrow stem cells when exposed to pulsatile flow, steady flow, and no flow
environments.
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CHAPTER II- LITERATURE REVIEW

Composition of the Aortic Heart Valve and Function
The aortic heart valve is composed of three leaflets, which open and close during systole
and diastole respectively. Over a single lifetime, hear valves will open and close at least
3x109 times (sacks 2015, heart valve function). The tissue and cells that constitute the
leaflets must have unique characteristics that allow them to open and close properly, as
well as remodel as needed4. The leaflets are comprise of three different layers, which
include the fibrosa (facing the artery), ventricularis (facing the ventricle), and the
spongiosa, which is located between the fibrosa and the ventricularis, each containing
different cells and molecules and each experiencing different fluid flow profiles7,12
(Figure 1). The ventricularis surface is exposed to a high velocities and unidirectional
shear stress, while the fibrosa side undergoes through OSS and lower velocities13. The
ventricularis side is composed of elastin, which is radially aligned, and collagen, with an
isotropic alignment. On the other hand, the fibrosa is longitudinally aligned collagen
fibers. The spongiosa, consists with glycosaminoglycan and proteoglycan, create a shear
slip buffer zone during leaflet movement12. These three layers provides the tensile
strength the valves need in order to resist the mechanical forces being exerted14.The
leaflets composition and structure allow them to endure demanding mechanical forces as
they function under a complex of cyclic tensile-flexure-shear stress, such as oscillatory
shear stress (OSS), loading environment3,14. During the cardiac cycle the heart pumps
about 3-5 liters of blood every minute through the valves 15 which results in transvalvular
pressures of 10mmHg in the pulmonary valve and 80mmHg in the aortic valve, as well as
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shear stress estimated values of 10-80dynes/cm² on the aortic valve16. The aortic valve,
needing to withstand very demanding and complex mechanical stress, makes it difficult
for prosthesis to endure without causing health risks on the patient.

Figure 1. Heart valve composition showing fibrosa,
spongiosa, and ventricularis. (Wirrig, 2013)

Valvular Endothelial Cells (VECs)
The leaflets are also composed of valvular endothelial cells (VECs) and of valvular
interstitial cells (VICs). Endothelial cells, lining most of the organs, carry many critical
function for blood and tissue homeostasis3. There are three main roles carried out by
valvular endothelial cells: regulation of coagulation, regulation of underlying interstitial
cells, and the diffusion or clearance of threatening agents from the blood3. It is well
established that the endothelial cells are the first responders to tissue damage, controlling
coagulative response to ensure clotting during injury. VECs have also shown to express
von Willebrand factor, a blood glycoprotein involved in homeostasis, and also modulate
the expression of factors involved in coagulation in response to shear stress3. However
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the dysfunction of VECs can result in many clinical conditions such as inflammatory
reactions, calcification and blood clots17.
As stated previously, shear stress is one of the main mechanical stresses found in blood
vessels and heart valves. Butcher et al. has previously shown that there are morphological
and behavioral differences between VECs and aortic endothelial cells due to the different
biomechanical environments they are exposed to2. Several groups have studied the effect
of shear stress on endothelial cells, and have demonstrated that VECs respond differently
by orienting perpendicular to flow and parallel to the circumferentially aligned
underlying tissue3; whereas vascular endothelial cells align parallel to flow regardless
matrix orientation18. VECs do not only show phenotypic differences from vascular
endothelial cells, they also express different genes as a response to fluid induced shear
stress. Aortic endothelial cells show an increase expression of proinflammatory genes
such as interlukins, connexin 43, BMP-4, and Collagen type II, all of which have been
shown to contribute to vascular endothelial cell inflammatory atherosclerosis. On the
other hand, VECs have shown a more abundant expression of anti-inflammatory genes
and a less abundant expression of pro-inflammatory genes, suggesting that VECs may be
innately more anti-inflammatory than aortic endothelial cells19. Previous studies have
also shown that VECs are more proliferative than aortic endothelial cells20.
One of endothelial cells unique characteristics is the ability to change from VECs to a
contractile myofibroblast-like VICs, a process called endothelial-mesenchymal
transformation (EMT)21. EMT has been shown to begin with endothelial cells losing cellcell contact and separating from the monolayer. Subsequently losing endothelial markers
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and gaining mesenchymal markers, and migrating to the interstitial space22.
Balachandran et al reported to induce endothelial cells to undergo EMT by applying a
pathological cyclic strain, suggesting that mechanical strain does regulate EMT in a
directionally dependent manner21.The role of EMT in the adult heart valve is not well
known, however it is a critical event for embryonic development of the heart valve23
(Figure 2).

Figure 2. EMT process during heart valve formation. Endothelial cells going through
EMT and migrating into the interstitial space (cardiac jelly) (Bischoff, 2007)

Valvular Interstitial Cells (VICs)
VICs are the most prevalent cell in the heart valve and are found in all three layers of the
valve24. The interstitial cells are made up of fibroblasts, smooth muscle cells, and
myofibroblast which share the characteristics as smooth muscle cells and fibroblasts25.
VICs main function is to maintain the structural integrity of the leaflets by constantly
remodeling the tissue and by secreting matrix metalloproteinases. The dualistic mode for
VICs is not well understood, however it is thought that the phenotype associated with
smooth muscle actin is involved in proliferation and migration. Furthermore, the
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contractile phenotype found on these cells is associated with the remodeling of the
extracellular matrix26. In vivo studies have suggested that VICs produce high amount of
proteins and glycosaminoglycans17.
It has been established that pulsatile hemodynamic shear stress, which found in the heart
valve, affects VICs through VECs as well as through other pathways including matrix
shear stress24. When VICs are applied a mechanical force they respond by altering
cellular stiffness and by producing matrix component24. Recent studies have shown
collagen production of VICs after being subjected to stretching forces, however the type
of collagen being produced was dependent on the level of the stretch. Collagen III gene
expression increased as the level of stretch increased as well24. Mechanical stresses,
sensed initially by VECs, are transduced by same to regulate VICs through paracrine
signaling. VECs also stimulate a decrease in VICs proliferation, an increase in protein
synthesis with shear stress, and a reduction of glycosaminoglycan loss under flow24.
Aortic Heart Valve Hemodynamics
The hemodynamic environment surrounding the heart valve, controls and ensures its
proper functionality. The heart valves, as previously mentioned, are exposed to different
mechanical stresses including, high levels of cyclic flexure, stretch and fluid-induced,
oscillatory shear stresses (OSS). Wall shear stress (WSS) is considered the most
important hemodynamic parameter for endothelial cells, defined by the following
equation: T w = 4µQ/πR³. Q is the volume flow rate, µis the viscosity and R is the radius
of the vessel. In blood vessels, the mean wall shear stress reported is believed to be 10-20
dynes/cm². However, WSS on the heart valves are difficult to obtain, and several groups
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have reported figures ranging from 20 dynes/cm² to 1000 dynes/cm² 3.In healthy heart
valves, the peak blood velocity, occurring at peak systole, on the aortic heart valve has
been shown to be 1.35± 0.35ms-1 27. However, due to the fact that each side of the leaflet
experience different velocity gradients, we would expect them experiencing different
shear stresses as well. The fibrosa side of the leaflet undergoes pulsatile unidirectional
shear stress, and the ventricularis undergoes oscillatory shear stress (OSS) caused by
vortices present on this side of the leaflet. These vortices are thought to facilitate the
movement of the leaflets to a close position during diastole25.
In addition to WSS, we have other mechanical components affecting the heart valves:
flexure and stretch.

Valvular leaflets are stained in a biaxial pattern, having peak

circumferential trains of approximately 10% and radial strain of more than 40%.28,29.
When opening, leaflets also experience a high degree of flexure, resulting in a
compressive strain in the fibrosa side and a tensile strain in the ventricularis side 30. Thus,
the fibrosa and the ventricularis undergo different mechanical stress patterns which could
affect the behavior of the endothelial and interstitial cells. However due to the
composition of the heart valves, they are able to withstand high mechanical stresses.
Heart Valve Disease
Heart valve diseases include, heart valve regurgitation, stenosis, and atresia.
Regurgitation occurs when the valve doesn’t close tightly causing blood to flow back into
the ventricle. Atresia consists of lacking an orifice or having the orifice abnormally
closed, preventing blood to pass through. In the case of stenosis, which is the most
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common condition in heart valve disease, involves the thickening and hardening of the
heart valve preventing the valve to fully open during the cardiac cycle (Figure 3).

Figure 3. The composition of a normal heart valve and a stenotic
heart valve (USC, 2012).

There are people who are born with this condition, congenital heart valve stenosis,
whereas other people develop AVS through their lifetime. Aortic valve stenosis (AVS)
was considered a “wear and tear” degenerative conditions which resulted in the formation
of calcium deposits in the heart valves. However, new evidence have shown that AVS
can be developed as part of a complex, regulated series of processes similar to
atherosclerosis31. As in atherosclerosis, the damaging of the endothelial layer due to an
increase in mechanical stresses, is thought to be the initial event for developing AVS.
Following endothelial injury, the same lipids involved in atherosclerosis, are shown to be
involved in heart valve calcification, in particular oxidized low-density lipoprotein
cholesterol (LDL) and lipoprotein A32. The lipid oxidation then establishes an
inflammatory response by recruiting macrophages, T lymphocytes and mast cells32. At
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this stage, studies have shown the initiation of calcium deposition in the area of injury,
which has been associated with cell death. Apoptotic bodies have demonstrated to have
similar characteristics as matrix vesicles found in bone32. Thus the formation of aortic
stenosis has been associated with inflammation and lipid deposition.
Endothelial damage can be caused by several factors, including abnormal hemodynamics
and tissue mechanics 3. It has been previously shown VECs undergoing physiological
shear tress values, respond by expressing anti-inflammatory genes, however when they
are exposed to abnormal fluid flow shear stress there was an activation of inflammatory
mediators33. Studies have also shown the activation of calcification genes, chondrogenic
genes, after VECs have been exposed to abnormal shear stresses33. Besides inducing the
cells to express calcific genes through shear stress, other studies have also shown an
increase in calcific gene expression when VECs are exposed to high levels of strain,
another innate mechanical force found in heart valves.
Yoganthan et al. has previously shown an even distribution of flow field during peak
systole on a normal heart valve with maximum velocity of 1.2 ms-1, while a jet-type flow
field with maximum velocity of 7.0 ms-1 was observed in a stenotic valve34. In the
stenotic heart valve, Yoganthan also observed a high turbulent shear layer around the
heart valve which could cause damage to the blood elements and the endothelial cells
lining the valve and the walls34.
Heart Valve Tissue Engineering
The replacement of the diseased heart valve, is not a common procedure done in order to
enhance the survival and quality of life of the patients. Current mechanical and
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bioprosthetic heart valves give the patient 15-20 years of adequate function in adults3.
However, the mechanical heart valves are prone to inflammation, infection and
thrombosis, while the bioprosthetic heart valves experience calcification on the valve
cusps, leading to regurgitation and reduced orifice area 35. Furthermore, in the pediatrics
application, reoperation are required in order to accommodate larger valve diameters as
they grow older. Tissue engineered heart valve (TEHV) has a great potential to generate
suitable viable heart valve replacement, and overcome the risks associated with
mechanical and bioprosthetic heart valves. The ideal heart valve is characterized as a
non-thrombogenic, viable living tissue that lasts the lifetime of the patient, providing
remodeling and repair of injuries and potentially allows somatic growth25.
The approach that most groups are implementing is the seeding of cells into a
biodegradable scaffold, and culturing the construct under appropriate environmental cues
to induce tissue formation, and then implanting these pre-conditioned constructs in
vivo35. Hoerstrup et al. pre-conditioned the construct using a pulsatile flow bioreactor
device and implanted the constructs into six lambs36. Through echocardiogram, the
leaflets were shown to function correctly without stenosis, thrombus or aneurysm up to
20 weeks. They also revealed a layer of cuspal tissue with collagen and elastin, and
covered by endothelium. Other groups have been using mesenchymal stem cells and the
biodegradable scaffold PGLA/PGA for TEHV. Mesenchymal stem cells, due to their
accessibility, self-renewal properties, and phenotypic plasticity under biochemical and
mechanical stimulation, are a promising cell source for tissue engineering. Sutherland et
al. has previously used ovine bone marrow stem cells to construct an autologous
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semilunar heart valve, which showed deposition of extracellular matrix and distribution
cell phenotypes reminiscent of that in a native pulmonary heart valve, after implantation
in a sheep37. We have previously created a construct using PGA/PLLA and BMSCs
cultured under flex-flow conditions in a bioreactor. We observed BMSC differentiation
and migration within the engineered tissue, leading to cells expressing endothelial
markers lining the surface, and cells expressing myofibroblast-markers within the tissue,
resembling the cell distribution in a native heart valve.
These advances can help us understand the multiscale hierarchical arrangements typically
found in heart valves, and therefore develop viable tissue engineered heart valves.
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CHAPTER III: STEM CELL STRUCTURAL ADAPTATION TO FLOW:
IMPLICATIONS FOR VALVULOGENESIS
Bone marrow stem cells (BMSCs) have been implicated in the development of heart
valve tissue engineering. OSS, a mechanical force present in heart valves, has been
shown to differentiate BMSCs into a cell showing endothelial cells markers.
Furthermore, OSS coupled with flexure has shown an increase of valvular endothelial
cells markers on BMSCs suggesting a potential differentiation of these cells. The
differentiation of stem cells has been linked to changes in actin filaments, causing a
change in gene expression. We previously observed the effects of oscillatory shear stress
(OSS) on the BMSC cytoskeleton after terminal chemical fixation of the cells. The
alterations in BMSC cytoskeleton during OSS has not yet been understood. Thus, in this
study we applied OSS to growing BMSCs to understand fundamental cellular structural
responses that precede the resulting gene expression, in the context of the heart valve
phenotype. By identifying these changes a deeper understanding of specific changes at
the cell structural-level, could be achieved and potentially fine tune the flow conditions to
achieve an optimized valvular phenotype.

INTRODUCTION
Critical valvular heart disease is a serious cardiovascular complication38. In infants,
congenital heart defects occur in four to six infants for every 1000 births39.
Approximately 24.5% of neonatal mortality is attributed to congenital heart defects40.
Among the plethora of cardiovascular defects, one of the more common, yet lifethreatening conditions is critical aortic valve stenosis (AVS), which results in high
mortality and morbidity despite early intervention41. Under normal circumstances, valve
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leaflet composition and structure permits endurance of demanding mechanical forces as
they function under a complex, coupled loading state of cyclic tensile, cyclic flexure-and
fluid-induced shear stresses, including oscillatory shear stresses (OSS)2. However, in
AVS, significant systolic transvalvular pressure gradients with a mean > 60mmHg
resulting from narrowing of the aortic root imposes considerable workload on the left
ventricle, resulting in rapid heart failure if left untreated17,35,42. Intervention to relieve
aortic valve stenosis in the neonate is usually approached via balloon dilation of the aortic
valve, performed through an interventional cardiac catheterization (balloon aortic
valvuloplasty/BAV).

Although the short term results are beneficial usually leading to

relief of the narrowed structure and temporary avoidance of the consequent left
ventricular failure, mid to long term prognosis is variable41. Moreover, sizing limitations,
risks associated with anti-coagulant use in children, accelerated calcification and an
inability to accommodate somatic growth severely limit use of commercially available
prosthetic valves for replacement of the infant’s stenosed valve.
Over the last ten years, tissue engineered heart valves (TEHVs) derived from stem cells
have been investigated to overcome the shortcomings associated with treatment of critical
valve anomalies in children. Recent studies have applied mechanical stimuli, to construct
superior tissue structures with properties resembling native heart valves, in particular,
using bone marrow-derived stem cells (BMSCs) seeded onto biodegradable scaffolds11,37.
BMSCs are a promising cell source due to their accessibility, self-renewal properties, and
phenotypic plasticity under biochemical and mechanical stimulation. Stem cell
differentiation using growth factors, molecular inhibitors, and biochemical cues have
been extensively studied, however the mechanotransduction regulatory pathways in stem
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cell differentiation remains uncertain43. Mechanical loads have shown to play an
important role in the development, growth, and maintenance of tissue functions, such as
the remodeling of cardiovascular tissues and bone formation44. Recent studies have
demonstrated that fluid-induced shear stresses can regulate mesenchymal stem cell
migration and stimulate stem cell differentiation into different cell lineages, including
osteoblasts and endothelial cells (ECs)45. However, the effect of mechanical forces in the
context of stem cells used in heart valve tissue engineering, where the mechanics play a
foundational role, is yet to be delineated. Nonetheless, a few pertinent, landmark studies
are summarized as follows: It was previously demonstrated that coupled flexure and flow
environments augmented tissue formation using PGA:PLLA scaffolds seeded with
BMSCs11. Elsewhere, Sutherland et al utilized BMSCs isolated from ovine and
PGLA/PGA biodegradable scaffolds to make autologous semilunar heart valves, which
were later implanted in sheep, and subsequently showed extracellular matrix and
distribution of cells in the engineered valve were similar to native heart valves37.
However, structural differences such as the absence of surface ridges in TEHVs were
evident and were thought to potentially result in early failure of these constructs11.
Mechanical stimuli are sensed by the cell membrane receptors which are later transferred
to the cytoskeleton; consequently this initiates a biochemical signaling cascade
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. In

BMSCs, the cytoskeletal structure has shown to be altered after exposure to fluid-induced
shear stress46. Fundamental changes in actin structure and distribution may thus closely
be linked to gene expression and protein synthesis in the shear stress stimulation of stem
cells3, similar to ECs47. The actin filaments of the cell cytoskeleton serve as structural
contributors to modulation of subsequent cell biological responses, including gene
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expression, cellular and matrix protein synthesis. In general, it has been shown that the
application of mechanical stress on actin filaments causes cytoskeleton reorganization
leading to tissue remodeling affecting stem cell viability, self-renewal, and
differentiation48, although detailed characterization of intracellular structures specifically
in response to fluid-induced shear stress is not known. In addition, other cellular
components such as focal adhesions, integrins, and the nucleus collectively play
important roles in modulating cellular biological responses37. For example, the
connection between the matrix and the cytoskeleton allows the cell to transmit external
forces to the cell’s nucleus, thus triggering biochemical signals such as the synthesis of
signaling proteins49.
We previously observed the effects of oscillatory shear stress (OSS) on the BMSC
cytoskeleton after terminal chemical fixation of the cells50. OSS regulates BMSC
structure and has been shown to be highly relevant to native heart valve development and
to TEHVs51. However, as was previously stated, the fluid-induced, OSS-related structural
changes that precede BMSC phenotypic switching and matrix production are not known.
Yet, identifying alterations in the BMSC cytoskeleton during OSS exposure may lead to a
deeper understanding of specific changes at the cell structural-level, that lead to
differential regulation, which in turn can be used to fine tune the flow conditions to
achieve an optimized valvular phenotype. Thus, in this investigation we applied OSS to
growing BMSCs to understand fundamental cellular structural responses that precede the
resulting gene expression, in the context of the heart valve phenotype. These efforts are
novel and unusual in that OSS is a relatively lesser known mechanical stimulus which to
our knowledge has never been applied in order to identify the structural responses of
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BMSCs; yet such a study is highly relevant to heart valve tissue engineering
developments.
METHODS
Culture and Expansion of BMSCs
Approximately 5x105 BMSCs/mL (Fisher Scientific, Pittsburgh, PA) were cultured in
T75 vented cell culture flask using AdvanceStem Mesenchymal Stem Cell Medium (GE
Healthcare Hyclone, Logan, UT) with 10% mesenchymal stem cell growth supplement
(GE Healthcare, Malborough, MA) and 1% penicillin and streptomycin (Fisher
Scientific, Waltham, CA) for growth and expansion. Cells were grown in a standard cell
culture incubator operating with 5% CO2 at 37°C with 95% humidity. BMSCs culture
expanded to passages 4 to 6 were utilized for subsequent studies.
BMSC Transfection
BMSCs were transfected for purposes of cell visualization with green fluorescent protein
(GFP) via electroporation as previously described52. In brief, a density of 1x106 BMSCs
were transfected using electroporation (Gene Pulser Xcell Electroporation System BIORAD, Hercules, CA) and plasmid-delivery of 60µg pTAGGFP-actin, a vector encoding
TagGFP fusion with actin used for labeling actin filaments in living cells (Evrogen,
Moscow, Russia). The following settings were used for electroporation: Exponential
Decay Pulse, Voltage of 350 V, capacitance of 950 uF, and Resistance: of 200 ohms52.
Transfection Efficiency
Cell viability and cell apoptosis was assessed using propidium iodide (PI) solution and
Annexin protein respectively following manufacturer supplied instructions (Biolegend,
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San Diego, CA). In brief, two days following transfection, BMSCs were re-suspended in
Annexin V Binding Buffer at a concentration of 2.5x 105 cells/ml. PI was added to 100µL
of cell suspension. After 15 min of incubation without light exposure, they were
evaluated by flow cytometry (BD Bioscientific, San Jose, CA).
Fluid-Induced Mechanobiology Experiments
Transfected BMSCs were plated in Collagen Type I (Fisher Scientific) coated
microchannels. A square wave was used in order to create a pulsatile flow environment to
which the cells were going to be exposed to using a shear stress cell assay system
(Fluxion Biosciences, South San Francisco, CA). Images of the cells under no flow,
steady flow and OSS environments were acquired using fluorescent microscopy
(Olympus IX81, CA) every hour for 5 hours for the first 2 days. After the second day,
cells were monitored every 24 hours. Cells in the no flow, steady-state (SS) flow and
OSS groups were cultured for a total of 3 days.
Cell Structure Quantification
Cell actin filaments and nucleus were quantified by analyses of images acquired during
the time course of the cell culture experiments (ImageJ, NIH Image, Bethesda, MD).
Actin filament quantification was performed using two metrics. The initial quantification
was based on simple filament counting.

For the second metric, the actin filament

distribution and deformation were observed. Quantification of the cell nucleus was
conducted by computing the nuclear eccentricity parameter. Nuclear eccentricity
(circularity) is a measure of nuclear elongation and is in a range of [0,1]; a circle has an
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eccentricity of 1 whereas a more elongated shape would be associated with a lower
number (ImageJ).
Statistical Analysis
One-way Anova followed by a Tukey’s post hoc test was conducted to test for any
significant differences between the three groups: no flow, SS and OSS (n=8 wells/group;
SPSS, V16, IBM, Armonk, NY). A statistically significant result was interpreted to have
occurred when p < 0.05.
RESULTS
Transfection Efficiency
GFP Transfection was initially found to occur in 77.4% of the cells. (Figure 4). However
of all the cells utilized, eventually ∼50% of the cells were found to be both viable and

Figure 4. Transfected BMSCs with actin GFP were assessed two days
after electroporation using flow cytometry; 77.43% of the cells were
shown to express high GFP intensity as seen in the first quadrant.
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successfully transfected (Figure 5). Viable transfected were subsequently segregated from

Figure 5. Transfected BMSCs with actin GFP assessed two days after
transfection were incubated in propidium iodide (PI) solution to evaluate
cellular viability; 50.07% of cells were efficiently transfected and viable
after electroporation, as seen in
the general population for use in subsequent experiment.

Number of Actin filaments
BMSC actin filaments increased in number by 122.6% after 48 hours of OSS (Figure 6).
On the other hand, cells exposed to SS demonstrated only an 18.2% increase in the
average number of filaments/cell after 48 hours of exposure, while the no flow group
displayed a marginal changes. The average increase in the number of filaments in cells
exposed to OSS compared to both SS and no flow groups was found to be significant (p <
0.05). However, there was no significant difference in comparing the average number of
filaments/cell between cells exposed to SS and no flow (p > 0.05).
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Figure 6.The effect of BMSC when exposed to OSS, SS, and No
Flow (static) conditions on the number of actin filaments (n=8
wells/group).

Figure 7. OSS, SS, and No Flow (static) conditions on average BMSC actin
filament length (n=8 wells/group).

23

F-actin filament length
There was a 53.8% decrease in the average length of the filaments after 48 hours in the
cells exposed to OSS (Figure 7). On the other hand, there was a 19.5% increase in
average filament length on cells exposed to SS and marginal changes in cells in the no
flow group. A significant decrease in the average actin filament length (p <0.05) in
BMSCs exposed to OSS compared to cells in both the SS and no flow groups was
observed.
Nuclear Eccentricity
We observed noticeable short term changes in nuclear shape in the SS and OSS groups
during the first five hours after treatment compared to the no flow controls (Figure 8).
However, after 48 hours, nuclear eccentricity was found to return to its original
configuration and was not found to be significantly different amongst the no flow, SS and

OSS groups (p < 0.05).
Figure 8. Nuclear eccentricity (circularity) in BMSCs while being exposed to OSS, SS,
and No Flow (static) conditions (n=8 wells/group).
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Figure 11. Transfected BMSCs imaged at No Flow (static) conditions at 0 hours
and at 48hours. Yellow arrows point to the actin filaments and red arrows show
the nucleus

Figure 10. Transfected cells showing filament orientation at 0 and 48 hours. SS group.

Figure 9. Transfected cells showing filament orientation under OSS.
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DISCUSSION
Pediatric patients suffering from congenital aortic valve anomalies such as a critical
valvular stenosis have extremely limited treatment options. Balloon aortic valvuloplasty
is typically performed longitudinally to relieve the narrowing and eventually the patient
may undergo a total valvular replacement with a prosthetic device. Unlike prosthetic
heart valves, TEHVs offer the possibility of overcoming the risks associated with
artificial valve replacement in children and by offering the potential to support somatic
growth. BMSCs remain a promising cell source because they promote tissue repair and
can differentiate along cardiovascular and valvular pathways. Biochemical environments
play a key role in determining cell fate and the differentiation of BMSCs. However,
recent studies that have applied mechanical stimuli to BMSCs clearly demonstrate that
the resulting cellular cues regulate proliferation and cell differentiation events;
chondrogenic, endothelial, as well as cardiomyocyte phenotypes have been observed 15.
BMSCs have been exposed to different mechanical stress states, such as tension,
compression, and fluid-induced shear stress7. The application of tensile strain has been
shown to result in an increased gene expression of bone markers, such as Runx2, alkaline
phosphate (ALP), collagen type I (Col1), and bone morphogenic proteins (BMPs) 7.
Recent studies have also shown the effect of mechanical stretch on the differentiation of
stem cells, resulting in an increase in ALP activity and extracellular matrix formation as
well as phosphorylation of focal adhesion kinase (FAK)13. A fundamental response to
mechanical stimuli can thus be observed within the cell cytoskeletal structure. For
example, McBeath et al. demonstrated that mechanical signals influence stem cell fate
through linkages between cell shape, cytoskeletal mechanics, and protein activation20.
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They disrupted the actin cytoskeleton using an actin-disrupting agent, cytochalastin D,
and were able to observe differentiation of stem cells towards adipocytes, rather than
osteocytes, suggesting a vital role of the cytoskeleton in the differentiation of stem cells
towards an osteoblast lineage. Similar to tensile strain, fluid induced shear stress has also
been shown to regulate osteogenic genes in BMSCs5. Specifically, upon exposure of
BMSCs to OSS, cells demonstrated an increase in calcium mobilization, and an increase
in expression of osteocalcin and osteopontin18. Furthermore, exposure of BMSCs to OSS
also increased DNA methylation, a central cellular mechanism for modulating gene
expression. We subsequently wanted to identify fundamental changes in BMSC structure
to OSS as a precursor to cellular signaling activity and eventual gene expression. A
priori knowledge of BMSC structural events leading to the valvular phenotype may be
leveraged to optimize engineered heart valve tissues intended for subsequent animal
studies or clinical translation. Such optimization is important in the context of enhancing
mechanical and biological resilience of the engineered construct when subjected to the in
vivo environment.
OSS is an innate mechanical state present on the surfaces of native heart valves and has
been hypothesized to enhance valve coaptation26. We previously demonstrated that the
actin filaments in BMSCs orient themselves parallel to the flow direction when exposed
to OSS23. In this study we applied a mean OSS of 1 dyne/cm2 and observed the changes
in actin filaments and the nucleus over 48 hours. The BMSCs exposed to OSS and SS
were found to orient themselves in the direction of flow (Figure 10, Figure 11) which is
not unlike ECs which also orient themselves in this manner4. Moreover, we found a
significant increase (p<0.05) in the average number of actin filaments (Figure 6) in
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BMSCs while being exposed to OSS (48 hours), which we speculate, could be a result of
augmented focal adhesions (FAs). FAs play an important role in the force-mediated
differentiation of stem cells 28. At the same time it has been reported that the formation of
FAs is rapidly activated by specific forces exerted on cells, thereby resulting in the
generation of additional actin filaments 28, which is indicative of what we observed here
for the BMSCs exposed to OSS. This finding therefore suggests that OSS may serve as a
more appropriate trigger of stem cell differentiation compared to uni-directional shear
stress. In particular, OSS may promote BMSC differentiation towards the cardiovascular
and valvular cell types as it is blood or fluid-induced and therefore highly relevant to
these phenotypes. We also observed a significant difference (p<0.05) in the average
length of actin filaments between the OSS and SS groups (Figure 7). We speculate that
the dramatic decrease in the length of actin filaments in BMSCs exposed to OSS could be
a result of the activation of cofilin, an actin-binding protein which disassembles actin
filaments
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. The context of this process is the similar response of endothelial cells to

fluid shear stress that results in dissociation of actin filaments, thereby permitting cellular
alignment to flow
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. Therefore, we speculate that a decrease in actin filament length

under OSS states to be a triggering event for mesenchymal to endothelial transformation,
an important process in promotion of an endothelium in the tissue engineered heart valve.
We have previously demonstrated that in fact, OSS states do augment the endothelial
phenotype in in vitro dynamically cultured engineered valvular tissues
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. Note that SS

conditions resulted in an increase in filament length (Figure 7) which may indicate
reduced actin disassembly and hence, more restrictive differential regulation of BMSCs
compared to OSS.
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In conclusion, we presented the changes in F-actin filaments and nuclear deformation
responses of BMSCs to OSS, SS and no flow conditions over a period of 48 hours.
Structural changes and differences were clearly observed between the groups.
Specifically, OSS-conditioned cells responded with a substantial increase in the number
of actin filaments but a considerable decrease in the length of the filaments. These events
could serve as structural precursors that may differentially regulate BMSCs towards a
valvular phenotype. On the other hand, we did not observe a significant difference in the
nuclear shape among the OSS, SS and no flow groups; however further studies need to be
conducted to determine the effects of fluid-induced nuclear deformation on BMSC
differentiation. Even though our results are preliminary, our study provides a simple, yet
unique perspective on specific cytoskeletal changes, particularly under OSS states that
could regulate stem cell fate in a manner conducive for engineering valvular tissues.
Nonetheless, further studies will be needed to confirm a direct correlation between the
cytoskeletal changes observed here to the differentiation and gene expression activity of
BMSCs.
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CHAPTER IV: OBSERVING CHANGES IN HEMODYNAMICS OF A HEALTHY
HEART VALVE AND A TREATED HEART VALVE USING A COMPUTATIONAL
MODEL
INTRODUCTION
Congenital heart defects are the most common birth defects, with about 1% of the
population being affected by them4. One of the most severe being critical aortic valve
stenosis (AVS), a life-threatening condition with high morbidity despite early
intervention. In AVS, significant systolic transvalvular pressure gradients with a mean >
60mmHg resulting from narrowing of the aortic root imposes considerable workload on
the left ventricle, resulting in rapid heart failure if left untreated3,35,42 . Open surgical
valvotomy and a less invasive procedure, transcatheter balloon valvuloplasty of the aortic
valve, are two of the most used and recognized procedures done in neonates with AVS.
Balloon valvuloplasty has been shown to reduce the pressure gradient across the aortic
valve around 60%6. Even though this procedure has shown promising results,
reintervention following aortic balloon valvuloplasty is high due to several factors,
including restenosis in one third of the patients6. Recent studies have shown that in
vascular endothelial cells, flow patterns are critical in the sense that they influence the
initiation of atherosclerosis, in-stent restenosis, and bypass graft failure6. After balloon
valvuloplasty, there is a relief in the pressure gradient across the aortic valve, however
the hemodynamics do not resemble that of a normal valve, which could play an important
role in the cause of restenosis. Valvular leaflet remodeling has been traced to endothelial
cell dysfunction and denudation2, which is the primary suspect for the cause of restenosis
in patients with balloon valvuloplasty. Valvular endothelial cells, like vascular
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endothelial cells, are known to remodel in response to hemodynamic environments by
sensing the mechanical signals, and reorganizing the cytoskeletal filaments and the focal
adhesion complexes, therefore altering gene expression2. By evaluating the changes in
hemodynamics following balloon intervention, we can delineate the potential primary
precursor which could be linked to underlying cause of rapid restenosis after balloon
implantation.
METHODS
Isolation of porcine valvular endothelial cells (VECs)
Side specific porcine valvular endothelial cells were isolated as previously described in
Gould, et.al 201053. In brief, porcine heart valves were dissected and valvular endothelial
cells from the ventricularis side and fibrosa side were dislodge using collagenase type II
(Worthington Biochemicals, Lakewood, NJ). After isolation, cells were grown for 3 days
for them to recover from the harsh process.
Immunostaining VECs
Isolated VECs were plated in pre-coated slides with collagen (BD Biosciences, Franklin
Lakes, NJ). The following procedure was followed for subsequent staining: Isolated cells
were cultured to ~80% confluence and fixed with 4% formaldehyde. Fixed cells were
permeabilized with 0.1%TritonX-100 for 5 min (this step was excluded for CD31
staining). Additional washing steps were performed three times with DPBS. Blocking
nonspecific epitopes was facilitated by adding 3% BSA in DPBS for 30 min. The primary
antibodies used were rabbit polyclonal anti-smooth muscle actin (Abcan, Cambridge,
MA) and goat polyclonal anti-CD31 (Abcan, Cambridge, MA). An overnight incubation
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at 4° was done. Samples were later washed and the second antibody was added for 1
hours at room temperature. Fixed cells were later viewed under a fluorescent microscope
(Olympus BX51, Center Valley, PA).
Computational Fluid Dynamics
In order to extract the shear stress waveforms, we conducted a CDF (Ansys Canonsburg,
PA) simulation depicting the aortic structure from the normal patient and the patient who
underwent balloon valvuloplasty. The geometry consisted of a 3D (x, y, and z
dimensions) structured mesh with 1.5million nodes. However analysis will be done along
the 2D plane from which the geometry was built because the cross-section of the valve
and artery geometry was not available from medical images. The measurements for each
patient were obtained from JDCH through a sonogram (Figure 12, Figure 13). The
velocity profile was fed to the inlet and the pressure profile was inputted to the output
(Figure 14, Figure 15, Figure 16, and Figure 17). A transient simulation was used,
placing the convergence criteria to 1x10-6 for momentum and continuity, with time steps

Figure 12. Echocardiography flow profiles from normal
patient obtained from JDCH.
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of 0.1s. Blood properties were used in order to run the model.

Figure 14. Echocardiography flow profiles from patient
after balloon valvuloplasty obtained from JDCH

Figure 13. Velocity profile from a normal fed to the inlet in the simulation (Ansys
CFD).
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Figure 16. Velocity profile from a patient after balloon valvuloplasty fed to the inlet in
the simulation (Ansys CFD)

Figure 15. Pressure profile from a normal patient fed to the outlet in the simulation
(Ansys CFD).
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Figure 17. Pressure profile from a patient after balloon valvuloplasty fed to the outlet in
the simulation (Ansys CFD).

RESULTS
Model Validation
In order to validate our model, the transvalvular pressure gradient from our model was
compared to the transvalvular pressure from the clinical data. The inlet pressure
waveform was also measured and compared the clinical data provided by the hospital.
For the post-balloon model, the pressure gradient calculated by our model was
26.06mmHg, whereas the clinical was 26.00mmHg, giving a 0.23% error (Figure. 18).
The inlet waveform calculated by the model is seen to resemble that of the clinical data
(Figure. 19). For the normal heart valve, the transvalvular pressure calculated by the
model was 8.20mmHg, while the clinical calculate measurement was 6.50mmHg,
estimating a 25.15% error (Figure.20). The error observed is negated by the fact that the

35

pressure drops are relatively small. Also, due to the fact that the pressure was not
measured directly using a catheter, clinical measurement may not be accurate, calculating
a high error. The calculated inlet pressure was 111.75mmHg, as compared to the
estimated value observed in clinical setting which was 120mmHg (Figure 21).

Figure 18. Transvavlular pressure gradient validation on the post-balloon
valvuloplasty model.
Computationa Inlet Pressure
Clinical Inlet Pressure

Figure 19. Inlet pressure waveform validation from treated heart valve.
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Figure 20. Transvalvular pressure gradient validation on the normal heart valve
model.

Figure 21 Inlet pressure validation from a healthy heart valve.
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Immunostaining of VECs
VECs were stained with CD31 to check for the presence of endothelial cells and α-SMA
to check for interstitial cells. Hoascht was used to stain the nucleus. We observe positive
staining for CD31 (Figure 18), whereas we do not observe positive staining for α-SMA
suggesting successful isolation of valvular endothelial cells.

Figure 22. Isolated VECs stained positive for CD31 (Left). VECs stained negative for αSMA (Right).
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Time-Averaged Wall Shear stress (TAWSS)
There is a clear difference in the TAWSS (axial) between the normal patient and the
patient who underwent balloon valvuloplasty on the fibrosa side. We observed peak shear
stresses of ~2.2Pa on the leaflets of the normal patient (Figure 23). However, on the
patient who underwent the treatment, we observed a peak wall shear stress of ~3.2Pa
(Figure 24). Furthermore we observe a difference in the waveform between both patients.

Figure 23. Time average wall shear stress on a normal patient.
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Figure 24. Time average wall shear stress on patient after treatment

Spatial-Averaged Wall Shear Stress
The axial wall shear stress was averaged spatially throughout the heart valve for each
time point. We observe a difference in the waveforms from the normal patient and the
patient after the treatment on the fibrosa side. Moreover the shear spatially-averaged wall
shear stress from the normal patient has a peak value of ~0.165 Pa (Figure 25), while
after the treatment the peak value is observed to be ~0.45 Pa (Figure 26).
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Figure 25. Spatially-averaged wall shear stress from the normal patient

Figure 26. Spatially-averaged wall shear stress after balloon
valvuloplasty.
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Oscillatory Shear Index (OSI)
OSI, is a measurement which quantifies the change in direction and magnitude of the
wall shear stress (WSS), and it is calculated with the following formula:
𝑇𝑇
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A Matlab code was created in order to measure the OSI throughout the valve. Side
specific OSI was measure, fibrosa and ventricularis. We observe higher OSI in the
fibrosa side compared to the ventricularis (Figure 27, Figure 28, Figure 29, and Figure
30). Comparing a healthy heart valve and a valve that underwent treatment, we also
observe a difference in the OSI. There is higher OSI in the fibrosa side of the treated
heart valve (Figure 27, Figure 29).
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Figure 27. OSI fibrosa side of the healthy heart valve
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Figure 28.OSI ventricularis side of the healthy heart valve.
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Figure 29. OSI fibrosa side of a heart valve that underwent treatment.
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Figure 30. OSI ventricularis side of the heart valve that underwent treatment.
DISCUSSION
Aortic valve stenosis (AVS) was considered to be caused by deterioration of the heart
valve which resulted in the formation of calcium deposits. However, recent studies have
shown that AVS can be developed as part of a complex series of processes similar to
atherosclerosis. As in atherosclerosis, the damaging of the endothelial layer due to an
increase in mechanical stresses, is thought to be the initial event for developing AVS.
Balloon aortic valvuloplasty, a treatment usually done on teenagers and children with
aortic valve stenosis, consists of the widening of the valve using a balloon catheter. The
balloon is inflated in between the valve in order to increase the effective orifice area and
improve the blood flow. This less invasive approach for aortic stenosis treatment, allows
the pressure gradient across the heart valve to decrease (~60%), however restenosis is
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observed soon after balloon intervention. Furthermore, flow profiles revealed by
echocardiograms of a healthy heart valve (Figure 12) and a heart valve after treated using
balloon valvuloplasty (Figure 13) show a difference in the velocity profiles. The peak
velocity calculated in the heart valve that underwent treatment was 1.11m/s, while the
peak velocity observed in the healthy heart valve was 0.66m/s. Even though this
treatment reduces the stenosis, this difference in the hemodynamics can inherently affect
the valvular endothelial function in a negative manner. Appropriate hemodynamics is
important for the function of the heart valve, however changes in velocities and pressures
can have consequences in the microscopic scales.
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In atherosclerosis, recent studies

have shown that the vascular endothelium is critical in the response of hemodynamic
stimuli, and that atherosclerosis and endothelial inflammation occurs at the areas of
disturbed flow
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. Furthermore, high shear stress gradients have also been observed to

alter endothelial cell function by altering growth factor and cytokine production, as well
as altering the permeability of macromolecules and lipoproteins
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. Similar to vascular

endothelial cells, valvular endothelial cells (VECs) dysfunction is coupled with disturbed
flow and leaflet degeneration and is also characterized by the expression of
proinflammatory receptors57.
Blood flow-induced shear stress is an important mechanical stimuli that is found in the
surface of the leaflets and it is important for VECs function. VECs have been shown to
respond to shear stress, as they change morphologically and genetically when they are
exposed to different shear stress conditions58. Shear stress profiles present in the fibrosa
differ from that in the ventricularis side as they are exposed to different flow profiles.
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The ventricularis side, undergoes high shear stress values, and unidirectional flow, while
the firbosa side experiences low shear stress values but oscillatory shear stress (OSS).
Shear tress values in a normal heart valve from the fibrosa go up to ~0.18 Pa (Figure 25)
and in the ventricularis values go up to ~28 Pa. Valvular pathology seems to occur
preferentially on the fribosa side, suggesting that oscillations observed in the firbosa side
may contribute to the calcification of the heart valves. The vortices present in the firbosa
side help the heart valve to close more efficiently at end systole. In our model we can
observe such oscillations, however we can see a higher magnitude of oscillations in the
treated heart valve. In order to quantify such oscillations we calculated the OSI from both
sides, fibrosa and ventricularis. The OSI in the ventricularis is negligible as the OSI≈0
(Figure 28, Figure 30), however in the fibrosa side we see a higher OSI value. An even
higher OSI distribution is observed in the heart valve which underwent balloon aortic
valvuloplasty treatment (Figure 27, Figure 29). This finding suggests aberrant fluid
oscillations along the arterial surface of the aortic valve that potentially may exceed
physiologically-healthy states. As a consequence, we interpret abnormal VEC signaling
and tissue factor activity may be provoked, leading to restenosed states. Confirmation of
this hypothesis is a focus of current efforts in our laboratory, wherein arterial-side aortic
VECs will be exposed to the aberrant levels of fluid-induced oscillations that were
identified here.

. Studies have shown endothelial phenotypes differ on opposite sides of

the aortic valve.58 The fibrosa side, which is more prone to lesion formation, has shown
to express multiple inhibitor of cardiovascular calcification in a lower degree than the
ventricularis side58. Therefore the increase in oscillations seen in the treated heart valve,
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may cause the valve to restenosis in a more rapid manner as the fibrosa side is more
vulnerable.
As we could observe in our model, there is a distinct difference in the hemodynamics of a
healthy heart valve and a heart valve that underwent balloon valvuloplasty. Changes in
hemodynamics have been linked to endothelial dysfunction, and therefore expression of
certain markers that may play a role in calcification. Further in vitro studies need to be
conducted in order to observe the response of the VECs to these altered profiles, such as
shear stress.
.
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CHAPTER V: FURTHER STUDIES

As we have demonstrated, there are structural changes happening in BMSCs when
exposed to OSS that may lead to the differentiation towards a valvular phenotype. We
have previously shown the expression of valvular endothelial cell markers in BMSCs
after being dynamically cultured using flex and OSS. We would like to confirm the
correlation between the cytoskeletal changes observed to the differentiation and gene
expression of BMSCs. Gene expression will be tested after BMSCs undergo OSS and SS
in order to link it to the cytoskeletal changes. We clearly have shown the difference in
averaged wall shear stress between the normal heart valve and one that has undergone
balloon valvuloplasty. This change in hemodynamics can potentially damage the
endothelial layer, which may lead to early calcification observed in patients that have
been treated with balloon valvuloplasty. Here we have only shown results from the
fibrosa side, however we would like to see the response of VECs in the ventricularis side
as they are exposed to a higher shear stress. Changes in actin filaments and focal
adhesions would be assessed as they have been shown to alter after being exposed to OSS
and SS.
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